Welcome to our dedicated page for Inspira Tech SEC filings (Ticker: IINNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inspira Technologies Oxy B.H.N. Ltd. filings document a foreign private issuer reporting on Form 6-K and incorporating selected reports by reference into Form F-3 and Form S-8 registration statements. Recent disclosures cover shareholder communications, strategic direction, shareholder meeting results, proxy voting matters, registration-statement references, and governance records.
The filings also describe company activity across its medical business and newer technology initiatives, including the INSPIRA™ ART100 life-support platform, the HYLA™ blood sensor, an Additively Manufactured Electronics platform branded QTREX, and quantum-connectivity applications such as cryogenic interconnect structures for superconducting quantum systems. Formal reports include material agreements, purchase-order disclosures, capital-structure context, and risk-related business updates tied to these operating areas.
Qtrex Quantum Ltd. reports that Nasdaq has confirmed the company has regained compliance with its listing standards for both minimum bid price and market value of listed securities. For the 11 consecutive business days from May 26 through June 9, 2026, the closing bid price of its ordinary shares was at or above $1.00 per share, and its market value of listed securities was $35,000,000 or greater, closing both deficiency matters. The report is also incorporated by reference into the company’s existing Form F-3 and Form S-8 registration statements.
Qtrex Quantum Ltd. reports that Nasdaq has confirmed the company has regained compliance with its listing standards for both minimum bid price and market value of listed securities. For the 11 consecutive business days from May 26 through June 9, 2026, the closing bid price of its ordinary shares was at or above $1.00 per share, and its market value of listed securities was $35,000,000 or greater, closing both deficiency matters. The report is also incorporated by reference into the company’s existing Form F-3 and Form S-8 registration statements.
QTREX Quantum Ltd. reported that the Israel Innovation Authority has awarded it an approximately $1 million government grant. The funding will support development of a purpose-built RF dielectric material designed for high-density, low-loss signal routing in superconducting quantum computing systems.
The material is being engineered as a native layer within QTREX’s quantum connectivity architecture, so the dielectric, conductor and 3D geometry can be optimized together. The company positions this as addressing a key bottleneck in scaling superconducting quantum computers, where more qubits require more RF lines, tighter packaging and lower thermal impact.
QTREX Quantum Ltd. reported that the Israel Innovation Authority has awarded it an approximately $1 million government grant. The funding will support development of a purpose-built RF dielectric material designed for high-density, low-loss signal routing in superconducting quantum computing systems.
The material is being engineered as a native layer within QTREX’s quantum connectivity architecture, so the dielectric, conductor and 3D geometry can be optimized together. The company positions this as addressing a key bottleneck in scaling superconducting quantum computers, where more qubits require more RF lines, tighter packaging and lower thermal impact.
QTREX Quantum Ltd. Chief Technology Officer Daniella Yechezkely Hayon reported an open-market sale of 50,000 Ordinary Shares at $3.00 per share. The sale followed the vesting of Restricted Share Units, where each RSU converted into one Ordinary Share. After this transaction, she directly holds 780,000 Ordinary Shares.
QTREX Quantum Ltd. Chief Technology Officer Daniella Yechezkely Hayon reported an open-market sale of 50,000 Ordinary Shares at $3.00 per share. The sale followed the vesting of Restricted Share Units, where each RSU converted into one Ordinary Share. After this transaction, she directly holds 780,000 Ordinary Shares.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units. The underlying shares were then sold under an existing Rule 10b5-1 trading plan, indicating the transactions were pre-scheduled.
The reported sales included 28,100 shares at $3.50 per share on May 31, 2026 and 1,900 shares at $3.51 per share on May 29, 2026. After these transactions, Yafit directly holds 870,000 Ordinary Shares, so the disposals represent a small portion of her overall position.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units. The underlying shares were then sold under an existing Rule 10b5-1 trading plan, indicating the transactions were pre-scheduled.
The reported sales included 28,100 shares at $3.50 per share on May 31, 2026 and 1,900 shares at $3.51 per share on May 29, 2026. After these transactions, Yafit directly holds 870,000 Ordinary Shares, so the disposals represent a small portion of her overall position.
QTREX Quantum Ltd. COO and VP of R&D Shabtay Abraham exercised employee stock options to acquire 95,239 Ordinary Shares on May 29, 2026. These exercises were reported as derivative transactions and did not involve any open‑market buying or selling.
Following the exercises, Abraham directly holds 1,332,713 Ordinary Shares. The options exercised came from grants made in 2020 that had fully vested by mid‑2022, with exercise prices disclosed in the footnotes in AUD and NIS terms.
QTREX Quantum Ltd. COO and VP of R&D Shabtay Abraham exercised employee stock options to acquire 95,239 Ordinary Shares on May 29, 2026. These exercises were reported as derivative transactions and did not involve any open‑market buying or selling.
Following the exercises, Abraham directly holds 1,332,713 Ordinary Shares. The options exercised came from grants made in 2020 that had fully vested by mid‑2022, with exercise prices disclosed in the footnotes in AUD and NIS terms.
QTREX Quantum Ltd. reported receiving a purchase order from a U.S.-based Fortune 500 multinational company for an Additively Manufactured Electronics (AME) system and related materials. The system will be delivered to one of the customer’s sites outside the United States and is designed to enable intricate electronic structures in a single workflow.
The company states that this order expands its commercial AME footprint with a global enterprise customer and reinforces its position as an advanced AME platform for demanding technology environments. QTREX expects the order to contribute to upcoming financial results and to support its growing AME commercial activity.
QTREX focuses on AME-based quantum connectivity solutions and mission-critical defense, aerospace, missile, space and other applications, while also working to monetize parts of its medical technology portfolio.
QTREX Quantum Ltd. reported receiving a purchase order from a U.S.-based Fortune 500 multinational company for an Additively Manufactured Electronics (AME) system and related materials. The system will be delivered to one of the customer’s sites outside the United States and is designed to enable intricate electronic structures in a single workflow.
The company states that this order expands its commercial AME footprint with a global enterprise customer and reinforces its position as an advanced AME platform for demanding technology environments. QTREX expects the order to contribute to upcoming financial results and to support its growing AME commercial activity.
QTREX focuses on AME-based quantum connectivity solutions and mission-critical defense, aerospace, missile, space and other applications, while also working to monetize parts of its medical technology portfolio.
QTREX Quantum Ltd. has raised $10 million in a private placement with a single institutional investor. The company is issuing 3,895,000 ordinary shares at $1.50 per share and pre-funded warrants for 2,771,667 shares at $1.4999 each, exercisable at $0.0001 per share. The deal closed on June 1, 2026 and the company plans to use the net proceeds for working capital and general corporate purposes.
The investor’s stake is capped by a 9.99% beneficial ownership limitation, with pre-funded warrants used to avoid exceeding that level. QTREX agreed not to issue additional ordinary shares or equivalents for 30 days after closing, subject to exceptions. A.G.P./Alliance Global Partners acted as exclusive placement agent, earning a 7.0% cash fee plus up to $50,000 in reimbursed expenses and $12,500 in non-accountable expenses.
Under a Registration Rights Agreement, QTREX must file a resale registration statement on Form F-3 (or another available form) within 5 trading days to cover the ordinary shares and shares underlying the pre-funded warrants, and use commercially reasonable efforts to have it declared effective within specified timeframes.
QTREX Quantum Ltd. has raised $10 million in a private placement with a single institutional investor. The company is issuing 3,895,000 ordinary shares at $1.50 per share and pre-funded warrants for 2,771,667 shares at $1.4999 each, exercisable at $0.0001 per share. The deal closed on June 1, 2026 and the company plans to use the net proceeds for working capital and general corporate purposes.
The investor’s stake is capped by a 9.99% beneficial ownership limitation, with pre-funded warrants used to avoid exceeding that level. QTREX agreed not to issue additional ordinary shares or equivalents for 30 days after closing, subject to exceptions. A.G.P./Alliance Global Partners acted as exclusive placement agent, earning a 7.0% cash fee plus up to $50,000 in reimbursed expenses and $12,500 in non-accountable expenses.
Under a Registration Rights Agreement, QTREX must file a resale registration statement on Form F-3 (or another available form) within 5 trading days to cover the ordinary shares and shares underlying the pre-funded warrants, and use commercially reasonable efforts to have it declared effective within specified timeframes.
The filing reports sales of ordinary shares by a holder identified as Yafit Tehila under Form 144. The excerpt lists three sell transactions: 30,000 shares on 05/27/2026 for $60,561.18, 30,000 shares on 05/28/2026 for $83,400.00, and 1,900 shares on 05/29/2026 for $6,675.46. The filing also records 160,000 shares issued upon vesting of RSUs to Quantum Ltd. on 02/05/2024. Other data in the excerpt (including a Nasdaq line and numeric fields) appear as issuer/security metadata.
The filing reports sales of ordinary shares by a holder identified as Yafit Tehila under Form 144. The excerpt lists three sell transactions: 30,000 shares on 05/27/2026 for $60,561.18, 30,000 shares on 05/28/2026 for $83,400.00, and 1,900 shares on 05/29/2026 for $6,675.46. The filing also records 160,000 shares issued upon vesting of RSUs to Quantum Ltd. on 02/05/2024. Other data in the excerpt (including a Nasdaq line and numeric fields) appear as issuer/security metadata.
Quantum Ltd. submitted a notice regarding 50,000 Ordinary Shares associated with brokerage Oppenheimer & Co. Inc. The filing lists an aggregate value of $150,000.00, a numeric identifier 35949247, an execution/record date of 05/29/2026, and Nasdaq as the market. The excerpt also shows 50,000 shares issued on 02/05/2024 upon vesting of RSUs to the holder named Quantum Ltd.
Quantum Ltd. submitted a notice regarding 50,000 Ordinary Shares associated with brokerage Oppenheimer & Co. Inc. The filing lists an aggregate value of $150,000.00, a numeric identifier 35949247, an execution/record date of 05/29/2026, and Nasdaq as the market. The excerpt also shows 50,000 shares issued on 02/05/2024 upon vesting of RSUs to the holder named Quantum Ltd.
IINN submitted a Form 144 notice reporting proposed sales of Ordinary Shares linked to recent option exercises. The filing lists 57,144 shares and 38,095 shares to be sold, each noted as "Shares acquired upon exercise of employee stock options," with the transactions dated 05/29/2026.
The filing names Oppenheimer & Co. Inc. as the broker and states "cash payment upon exercise of stock options" as the acquisition method. The Form 144 is a regulatory notice of intended resale under the Securities Act.
IINN submitted a Form 144 notice reporting proposed sales of Ordinary Shares linked to recent option exercises. The filing lists 57,144 shares and 38,095 shares to be sold, each noted as "Shares acquired upon exercise of employee stock options," with the transactions dated 05/29/2026.
The filing names Oppenheimer & Co. Inc. as the broker and states "cash payment upon exercise of stock options" as the acquisition method. The Form 144 is a regulatory notice of intended resale under the Securities Act.